To evaluate the safety and efficacy of Unani medicines( Karafas and Duqu) in the management of Urolithiasis.
Phase 2
- Conditions
- Health Condition 1: null- Hasal al Kulya wa Masana(Urolithiasis)
- Registration Number
- CTRI/2017/08/009407
- Lead Sponsor
- Govt Nizamia Tibbi College Hyderabad
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
1.Patients with established Sangi Gurda wa Masana (Urolithiasis) proved by radiological or sonological investigations.
2.Hematologic and Biochemical parameters within normal limits.
3.Patients with normal liver and kidney function.
3.Patients willing to continue whole period of trial with their written consent.
Exclusion Criteria
1.Patients with impaired liver and kidney function.
2.Patients with urolithiasis causing obstruction needing emergency management.
3.Patients already on some medication for urolithiasis.
4.Pregnant and lactating women.
5.Patients unwilling to provide informed consent or abide by the requirements of the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Symptomatic relief from clinical symptoms of urolithiasisTimepoint: 06 weeks
- Secondary Outcome Measures
Name Time Method Reduction in size of stone or expulsion of stone by viewing ultrasonological impression.Timepoint: 06 weeks